CIVIS launched a new series of Blended Intensive Programmes – BIPs, a new format of Erasmus+ mobility.
Students in medicine, health and related areas from all levels of studies have the opportunity to apply to three BIPs with deadline on 30 November 2022:
- Experimental Models in Molecular Biomedicine (EMMB)
- Molecular Scale Biophysics
- Technical Innovations: Applications to Immuno-Oncology
The period of application for these programmes closes on 30 November 2022. All BIPs applications take place through the CIVIS mobility portal, which can be accessed directly from the listings in the CIVIS Course Catalogue here.
Every BIP combines online teaching with a short period of physical mobility, where you can spend 5 days at another university with students from across the CIVIS Alliance. By combining online sessions with a short trip for face-to-face teaching, this innovative format opens up opportunities for international study to new groups of students.
Each BIP is developed, organised and taught by academics at three or more CIVIS member universities. These CIVIS programmes use interdisciplinary teaching and learning. Anchored in academic excellence, these courses often cross the borders of traditions subjects, university cycles or faculties.
CIVIS is a European University Alliance gathering 11 member universities: Aix-Marseille Université (France), National and Kapodistrian University of Athens (Greece), University of Bucharest (Romania), Université libre de Bruxelles (Belgium), Universidad Autónoma de Madrid (Spain), Sapienza Università di Roma (Italia), Stockholm University (Sweden), Eberhard Karls Universität Tübingen (Germany), University of Glasgow (UK), Paris Lodron University of Salzburg (Austria) and University of Lausanne (Switzerland). Selected by the European Commission as one of the first 17 European Universities pilots, it brings together around half a million students and more than 70 000 staff members, including 37 400 academics and researchers.